What is Zetta Genomics?
Zetta Genomics operates at the intersection of bioinformatics and enterprise-level data architecture. Its core offering, XetaBase, serves as a genomic-native platform designed to streamline the storage, management, and real-time analysis of massive datasets. By providing a robust framework for both research and clinical applications, the company enables healthcare systems and life sciences organizations to unlock the latent value within genomic sequences. This technological foundation is critical for the advancement of precision medicine, where the ability to process complex data efficiently directly correlates to improved patient outcomes and accelerated drug discovery cycles.
How much funding has Zetta Genomics raised?
Zetta Genomics has raised a total of $7.7M across 1 funding round:
Angel/Seed
$7.7M
Angel/Seed (2024): $7.7M with participation from APEX Ventures, Cambridge Enterprise, We Venture Capital, and Nina Capital
Key Investors in Zetta Genomics
APEX Ventures
APEX Ventures is a venture capital firm focused on deep-tech and medical innovations, aiming to build the next generation of world-leading companies.
Nina Capital
Nina Capital is a specialized venture capital firm focused on investing in health technology companies at the pre-seed and seed stages.
Cambridge Enterprise
Cambridge Enterprise is the commercialization arm of the University of Cambridge, supporting the translation of research into impactful commercial ventures.
What's next for Zetta Genomics?
Looking ahead, the strategic deployment of this capital will likely focus on expanding the reach of XetaBase across global healthcare markets. As the demand for scalable genomic infrastructure grows, Zetta Genomics is expected to prioritize the integration of its platform with existing clinical workflows, thereby reducing the friction associated with genomic data adoption. Furthermore, the company is well-positioned to deepen its collaborations with research institutions, fostering an ecosystem where data-driven insights can be translated into therapeutic breakthroughs. By maintaining its focus on high-performance computing and data integrity, Zetta Genomics is set to solidify its role as a foundational player in the future of digital health.
See full Zetta Genomics company page
